Evidence map›Paper›PMID 28840937›Full record

ArticleBiotechnology and bioengineering2017

Impact of growth mode, phase, and rate on the metabolic state of the extremely thermophilic archaeon Pyrococcus furiosus.

Piyum A Khatibi, Chung-Jung Chou, Andrew J Loder, Jeffrey V Zurawski, Michael W W Adams, Robert M Kelly

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Piyum A KhatibiDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina.
Chung-Jung ChouDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina.
Andrew J LoderDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina.
Jeffrey V ZurawskiDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina.
Michael W W AdamsDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia.
Robert M KellyDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina.ORCID 0000-0002-0639-3592

Funding

Molecular Biotechnology Training at North Carolina State UniversityT32GM008776 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI KELLY, ROBERT M · 2000 to 2019
$3.9M
NIGMS NIH HHS T32 GM008776
6 · The paper itself

Abstract

The archaeon Pyrococcus furiosus is emerging as a metabolic engineering platform for production of fuels and chemicals, such that more must be known about this organism's characteristics in bioprocessing contexts. Its ability to grow at temperatures from 70 to greater than 100°C and thereby avoid contamination, offers the opportunity for long duration, continuous bioprocesses as an alternative to batch systems. Toward that end, we analyzed the transcriptome of P. furiosus to reveal its metabolic state during different growth modes that are relevant to bioprocessing. As cells progressed from exponential to stationary phase in batch cultures, genes involved in biosynthetic pathways important to replacing diminishing supplies of key nutrients and genes responsible for the onset of stress responses were up-regulated. In contrast, during continuous culture, the progression to higher dilution rates down-regulated many biosynthetic processes as nutrient supplies were increased. Most interesting was the contrast between batch exponential phase and continuous culture at comparable growth rates (∼0.4 hr

Indexed as

Archaeal ProteinsBatch Cell Culture TechniquesCell ProliferationEnergy MetabolismPyrococcus furiosusTranscriptomeArchaeal Proteinscontinuous culturegrowth phasegrowth ratehyperthermophilesPyrococcus furiosustranscriptome

Identifiers

PMID28840937
PMCPMC5809124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.